Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth ...
Hosted on MSN5mon
Medical Device Maker Nova Biomedical Is Exploring a SaleNova Biomedical develops and manufactures medical devices and diagnostics equipment that can be used by health-care providers for advanced blood testing and analysis, according to its website.
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday.Invest with Confidence: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback